Terms: = Endocrine gland cancer AND YWHAE, P62258, 7531, ENSG00000108953, 14-3-3 epsilon, FLJ45465, MDS, MDCR, KCIP-1, 14-3-3E AND Treatment
36 results:
1. Comparison Between Plastic and Metallic Biliary Stent Placement for Preoperative Patients with Pancreatic Head cancer: A Systematic Review and Meta-Analysis.
Endo Y; Tanaka M; Kitago M; Yagi H; Abe Y; Hasegawa Y; Hori S; Nakano Y; Iwasaki E; Kitagawa Y
Ann Surg Oncol; 2024 Feb; 31(2):1319-1327. PubMed ID: 37952017
[TBL] [Abstract] [Full Text] [Related]
2. Multi-Maintenance Olaparib Therapy in Relapsed, Germline BRCA1/2-Mutant High-Grade Serous Ovarian cancer (MOLTO): A Phase II Trial.
Morgan RD; Clamp AR; White DJ; Price M; Burghel GJ; Ryder WDJ; Mahmood RD; Murphy AD; Hasan J; Mitchell CL; Salih Z; Wheeler C; Buckley E; Truelove J; King G; Ainaoui Y; Bhaskar SS; Shaw J; Evans DGR; Kilerci B; Pearce SP; Brady G; Dive C; O'Connor JPB; Wallace AJ; Rothwell DG; Edmondson RJ; Jayson GC
Clin Cancer Res; 2023 Jul; 29(14):2602-2611. PubMed ID: 36799931
[TBL] [Abstract] [Full Text] [Related]
3. Prescribing pattern of anticoagulants in patients with cancer associated thrombosis: Results of a survey among MITO group and AIOM society.
Milani A; Tuninetti V; Pignata S; Lorusso D; Castaldo D; De Giorgi U; Savarese A; Biglia N; Scandurra G; Mangili G; Di Maio M; Turinetto M; Bellero M; Mammoliti S; Testa S; Scotto G; Purro A; Artioli G; Valabrega G
Tumori; 2023 Oct; 109(5):490-495. PubMed ID: 36609207
[TBL] [Abstract] [Full Text] [Related]
4. Antiproliferative potential of
Sayed AM; El-Hawary SS; Abdelmohsen UR; Ghareeb MA
Food Funct; 2022 Nov; 13(22):11733-11743. PubMed ID: 36281695
[No Abstract] [Full Text] [Related]
5. Hematological disorders after salvage PARPi treatment for ovarian cancer: Cytogenetic and molecular defects and clinical outcomes.
Todisco E; Gigli F; Ronchini C; Amato V; Sammassimo S; Pastano R; Parma G; Lapresa MT; Bertolini F; Corsini C; Gregato G; Poletti C; Pelicci PG; Alcalay M; Colombo N; Tarella C
Int J Cancer; 2022 Nov; 151(10):1791-1803. PubMed ID: 35695283
[TBL] [Abstract] [Full Text] [Related]
6. Serum Prolactin Level to Tumor Size Ratio as a Potential Parameter for Preoperative Differentiation of Prolactinomas from Hyperprolactinemia-Causing Non-functional Pituitary Adenomas.
Kim JH; Hur KY; Hong SD; Choi JW; Seol HJ; Nam DH; Lee JI; Kong DS
World Neurosurg; 2022 Mar; 159():e488-e496. PubMed ID: 34958988
[TBL] [Abstract] [Full Text] [Related]
7. Infiltration of thyroid papillary cancer tissue with myeloid leukemic cells: a case report.
Sözen M; Vural Ç; Selek A; Kiraz U; Cantürk Z; Çetinarslan B; Gezer E; Köksalan D
World J Surg Oncol; 2021 Jul; 19(1):225. PubMed ID: 34325712
[TBL] [Abstract] [Full Text] [Related]
8. Long-term safety in patients with recurrent ovarian cancer treated with niraparib versus placebo: Results from the phase III ENGOT-OV16/NOVA trial.
Mirza MR; Benigno B; Dørum A; Mahner S; Bessette P; Barceló IB; Berton-Rigaud D; Ledermann JA; Rimel BJ; Herrstedt J; Lau S; du Bois A; Herráez AC; Kalbacher E; Buscema J; Lorusso D; Vergote I; Levy T; Wang P; de Jong FA; Gupta D; Matulonis UA
Gynecol Oncol; 2020 Nov; 159(2):442-448. PubMed ID: 32981695
[TBL] [Abstract] [Full Text] [Related]
9. Patient preferences for maintenance PARP inhibitor therapy in ovarian cancer treatment.
Havrilesky LJ; Lim S; Ehrisman JA; Lorenzo A; Alvarez Secord A; Yang JC; Johnson FR; Gonzalez JM; Reed SD
Gynecol Oncol; 2020 Mar; 156(3):561-567. PubMed ID: 31982178
[TBL] [Abstract] [Full Text] [Related]
10. A phase II randomized, double-blind trial of a polyvalent Vaccine-KLH conjugate (NSC 748933 IND# 14384) + OPT-821 versus OPT-821 in patients with epithelial ovarian, fallopian tube, or peritoneal cancer who are in second or third complete remission: An NRG Oncology/GOG study.
O'Cearbhaill RE; Deng W; Chen LM; Lucci JA; Behbakht K; Spirtos NM; Muller CY; Benigno BB; Powell MA; Berry E; Tewari KS; Hanjani P; Lankes HA; Aghajanian C; Sabbatini PJ
Gynecol Oncol; 2019 Dec; 155(3):393-399. PubMed ID: 31653510
[TBL] [Abstract] [Full Text] [Related]
11. Identification of Key Candidate Genes and Pathways for Relationship between Ovarian cancer and Diabetes Mellitus Using Bioinformatical Analysis.
Sun Y; Xiaoyan H; Yun L; Chaoqun L; Jialing W; Liu Y; Yingqi Z; Peipei Y; Junjun P; Yuanming L
Asian Pac J Cancer Prev; 2019 Jan; 20(1):145-155. PubMed ID: 30678426
[TBL] [Abstract] [Full Text] [Related]
12. Salvage peptide receptor radionuclide therapy with [
van der Zwan WA; Brabander T; Kam BLR; Teunissen JJM; Feelders RA; Hofland J; Krenning EP; de Herder WW
Eur J Nucl Med Mol Imaging; 2019 Mar; 46(3):704-717. PubMed ID: 30267116
[TBL] [Abstract] [Full Text] [Related]
13. The poly (ADP ribose) polymerase inhibitor niraparib: Management of toxicities.
Moore KN; Mirza MR; Matulonis UA
Gynecol Oncol; 2018 Apr; 149(1):214-220. PubMed ID: 29397193
[TBL] [Abstract] [Full Text] [Related]
14. Risk of developing chronic myeloid neoplasms in well-differentiated thyroid cancer patients treated with radioactive iodine.
Molenaar RJ; Pleyer C; Radivoyevitch T; Sidana S; Godley A; Advani AS; Gerds AT; Carraway HE; Kalaycio M; Nazha A; Adelstein DJ; Nasr C; Angelini D; Maciejewski JP; Majhail N; Sekeres MA; Mukherjee S
Leukemia; 2018 Apr; 32(4):952-959. PubMed ID: 29104287
[TBL] [Abstract] [Full Text] [Related]
15. Persistent Hematologic Dysfunction after Peptide Receptor Radionuclide Therapy with
Bergsma H; van Lom K; Raaijmakers MHGP; Konijnenberg M; Kam BLBLR; Teunissen JJM; de Herder WW; Krenning EP; Kwekkeboom DJ
J Nucl Med; 2018 Mar; 59(3):452-458. PubMed ID: 28775205
[TBL] [Abstract] [Full Text] [Related]
16. Olaparib in combination with irinotecan, cisplatin, and mitomycin C in patients with advanced pancreatic cancer.
Yarchoan M; Myzak MC; Johnson BA; De Jesus-Acosta A; Le DT; Jaffee EM; Azad NS; Donehower RC; Zheng L; Oberstein PE; Fine RL; Laheru DA; Goggins M
Oncotarget; 2017 Jul; 8(27):44073-44081. PubMed ID: 28454122
[TBL] [Abstract] [Full Text] [Related]
17. Laparoscopic versus open distal pancreatectomy for pancreatic cancer.
Riviere D; Gurusamy KS; Kooby DA; Vollmer CM; Besselink MG; Davidson BR; van Laarhoven CJ
Cochrane Database Syst Rev; 2016 Apr; 4(4):CD011391. PubMed ID: 27043078
[TBL] [Abstract] [Full Text] [Related]
18. Pylorus-preserving pancreaticoduodenectomy (pp Whipple) versus pancreaticoduodenectomy (classic Whipple) for surgical treatment of periampullary and pancreatic carcinoma.
Hüttner FJ; Fitzmaurice C; Schwarzer G; Seiler CM; Antes G; Büchler MW; Diener MK
Cochrane Database Syst Rev; 2016 Feb; 2(2):CD006053. PubMed ID: 26905229
[TBL] [Abstract] [Full Text] [Related]
19. Pylorus-preserving pancreaticoduodenectomy (pp Whipple) versus pancreaticoduodenectomy (classic Whipple) for surgical treatment of periampullary and pancreatic carcinoma.
Diener MK; Fitzmaurice C; Schwarzer G; Seiler CM; Hüttner FJ; Antes G; Knaebel HP; Büchler MW
Cochrane Database Syst Rev; 2014 Nov; 11(11):CD006053. PubMed ID: 25387229
[TBL] [Abstract] [Full Text] [Related]
20. Therapy-related myelodysplasia and acute myeloid leukemia.
Bhatia S
Semin Oncol; 2013 Dec; 40(6):666-75. PubMed ID: 24331189
[TBL] [Abstract] [Full Text] [Related]
[Next]
